Mometasone Furoate: A Well-Established Topical Corticosteroid now with Improved Galenic Formulations
- *Corresponding Author:
- Dr. Antonio Guilabert
Unidad de Dermatologia. Hospital de Granollers
Av Francesc Ribas s/n 08402, Granollers, Spain
Email: [email protected]
Received date: June 05, 2013; Accepted date: September 21, 2013; Published date: September 28, 2013
Citation: Molin S, Abeck D, Guilabert A, Bellosta M (2013) Mometasone Furoate: A Well-Established Topical Corticosteroid now with Improved Galenic Formulations. J Clin Exp Dermatol Res 4:184. doi: 10.4172/2155-9554.1000184
Copyright: © 2013 Molin S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Mometasone furoate is an established topical corticosteroid that is frequently used for the treatment of inflammatory skin diseases because it offers a balanced efficacy and safety profile. The type of vehicle of a topical corticosteroid has impact not only on its efficacy but also on the patients’ adherence to treatment. Traditional formulations of mometasone furoate might have not properly fulfilled all the ideal features required for its use in topical treatment. Extensive research has recently been performed and new formulations have been developed that will be available shortly. The aim of this review is to give a thorough overview on the substance mometason furoate and the available clinical data with a special focus on the newly developed galenic formulations.